{"id":11119,"date":"2025-03-11T03:03:01","date_gmt":"2025-03-11T10:03:01","guid":{"rendered":"https:\/\/www.prfire.com\/news-releases\/4d-medicine-launches-new-corporate-website-to-showcase-next-generation-bioabsorbable-polymer-and-medical-device-solutions\/"},"modified":"2025-03-11T03:03:01","modified_gmt":"2025-03-11T10:03:01","slug":"4d-medicine-launches-new-corporate-website-to-showcase-next-generation-bioabsorbable-polymer-and-medical-device-solutions","status":"publish","type":"news-releases","link":"https:\/\/www.prfire.com\/news-releases\/4d-medicine-launches-new-corporate-website-to-showcase-next-generation-bioabsorbable-polymer-and-medical-device-solutions\/","title":{"rendered":"4D Medicine Launches New Corporate Website to Showcase Next-Generation Bioabsorbable Polymer and Medical Device Solutions"},"content":{"rendered":"<div class=\"trix-content\">\n<div>\n<strong>NOTTINGHAM, UK. March 11th, 2025<\/strong> \u2013 4D Medicine Ltd, an emerging innovator in the biomaterials and medical device sector, is proud to announce the launch of its newly redesigned corporate website, <a href=\"https:\/\/4dmedicine.co.uk\/\" target=\"_blank\" rel=\"noopener\">www.4dmedicine.co.uk<\/a>. <\/p>\n<p>The site is designed to offer a comprehensive resource for investors, strategic partners, and healthcare professionals, highlighting the company\u2019s groundbreaking <a href=\"https:\/\/4dmedicine.co.uk\/biomaterials\/\" target=\"_blank\" rel=\"noopener\">4Degra\u00ae<\/a> bioabsorbable polymer technology and its potential to transform the medical device industry.<\/p>\n<\/div>\n<div>The new website offers information on the unique properties of 4Degra\u00ae, a next-generation bioabsorbable polymer developed to improve patient outcomes in medical device applications. 4Degra\u00ae\u2019s unparalleled versatility and biocompatibility make it an ideal material for a wide range of devices, including those used in musculoskeletal repair, soft tissue regeneration and drug-delivery.<\/p>\n<\/div>\n<div>\u201c4Degra\u00ae represents the next evolution in bioabsorbable materials, and this website serves as an essential tool to communicate the exciting opportunities that lie ahead for investors and collaborators,\u201d said Phil Smith, CEO of 4D Medicine.\u00a0<\/p>\n<p>\u201cWe\u2019ve designed the site to not only inform but to also demonstrate the potential impact our technology can have in improving surgical outcomes and improving lives.\u201d<\/p>\n<\/div>\n<div>Key features of the new website include:<\/div>\n<ul>\n<li>\n<strong>Investor Section<\/strong>: Offering an overview of the value proposition presented by the 4Degra\u00ae biomaterial technology and providing a portal to access key financial data, company milestones, and investment opportunities for stakeholders seeking to partner with 4D Medicine.<\/li>\n<li>\n<strong>Technology Overview<\/strong>: Delivering information on the science behind 4Degra\u00ae, its unique properties, and its broad range of applications across multiple implantable medical device sectors.<\/li>\n<li>\n<strong>Partnering Opportunities<\/strong>: Highlighting the company\u2019s commitment to strategic collaborations and joint ventures aimed at bringing innovative medical devices to market.<\/li>\n<li>\n<strong>News<\/strong>: A dedicated space for press releases, announcements, and industry insights, keeping visitors informed of the latest developments at 4D Medicine.<\/li>\n<\/ul>\n<div>The launch of this website underscores 4D Medicine\u2019s commitment to transparency, collaboration, and ongoing innovation. The company is poised to lead the way in delivering solutions that enhance patient care and create lasting value for its partners and stakeholders.<\/div>\n<div><\/div>\n<div>ENDS<\/div>\n<\/div>\n","protected":false},"author":1,"featured_media":11120,"menu_order":0,"template":"","meta":{"_acf_changed":false,"content-type":"","site-sidebar-layout":"default","site-content-layout":"default","ast-global-header-display":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":""},"news-rooms":[7317],"press-tags":[6891,7319,3307,3907,6325,7318,7320],"press-categories":[2552,2522,2532,2513],"class_list":["post-11119","news-releases","type-news-releases","status-publish","has-post-thumbnail","hentry","news-rooms-4d-medicine-limited","press-tags-3d-printing","press-tags-bioabsorbable","press-tags-biomaterials","press-tags-implant","press-tags-medical","press-tags-medical-device","press-tags-polymer","press-categories-business","press-categories-medical","press-categories-science","press-categories-technology"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.prfire.com\/wp-json\/wp\/v2\/news-releases\/11119","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.prfire.com\/wp-json\/wp\/v2\/news-releases"}],"about":[{"href":"https:\/\/www.prfire.com\/wp-json\/wp\/v2\/types\/news-releases"}],"author":[{"embeddable":true,"href":"https:\/\/www.prfire.com\/wp-json\/wp\/v2\/users\/1"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.prfire.com\/wp-json\/wp\/v2\/media\/11120"}],"wp:attachment":[{"href":"https:\/\/www.prfire.com\/wp-json\/wp\/v2\/media?parent=11119"}],"wp:term":[{"taxonomy":"news-rooms","embeddable":true,"href":"https:\/\/www.prfire.com\/wp-json\/wp\/v2\/news-rooms?post=11119"},{"taxonomy":"press-tags","embeddable":true,"href":"https:\/\/www.prfire.com\/wp-json\/wp\/v2\/press-tags?post=11119"},{"taxonomy":"press-categories","embeddable":true,"href":"https:\/\/www.prfire.com\/wp-json\/wp\/v2\/press-categories?post=11119"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}